Home › Stocks › OLMA › All Fund Holders
OLMA — OLEMA PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 37 · Reported value held: $597.13M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) history | Q2 2026 | 12.14M | $151.91M | 0.01% | Add |
| Janus Henderson Group history | Q1 2026 | 7.11M | $106.01M | 0.05% | Add |
| Vanguard Group history | Q4 2025 | 3.56M | $89.03M | 0.00% | Add |
| BlackRock Inc history | Q2 2026 | 6.71M | $84.00M | 0.00% | Add |
| Franklin Resources history | Q2 2026 | 2.35M | $29.39M | 0.01% | Add |
| Morgan Stanley history | Q2 2026 | 1.83M | $22.92M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 1.82M | $22.76M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 1.57M | $19.62M | 0.01% | Add |
| Two Sigma Investments history | Q2 2026 | 1.13M | $14.15M | 0.01% | Reduce |
| Marshall Wace history | Q4 2025 | 360.39K | $9.01M | 0.01% | New |
| Northern Trust Corp history | Q2 2026 | 674.95K | $8.44M | 0.00% | Add |
| Wellington Management Group history | Q2 2026 | 526.45K | $6.59M | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 518.34K | $6.48M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 334.88K | $4.19M | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 222.87K | $2.79M | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 222.18K | $2.78M | 0.00% | Add |
| Millennium Management history | Q1 2026 | 182.94K | $2.73M | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 143.28K | $1.75M | 0.00% | New |
| Citigroup Inc history | Q2 2026 | 125.56K | $1.57M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 117.41K | $1.47M | 0.00% | Reduce |
| Balyasny Asset Management history | Q1 2026 | 89.67K | $1.34M | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 95.83K | $1.20M | 0.00% | Reduce |
| Manulife Financial history | Q2 2026 | 89.99K | $1.13M | 0.00% | Reduce |
| AQR Capital Management history | Q2 2026 | 78.16K | $977.79K | 0.00% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 67.67K | $846.51K | 0.00% | Add |
| Prudential Financial history | Q2 2026 | 60.06K | $751.35K | 0.00% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 55.52K | $694.54K | 0.00% | Add |
| Renaissance Technologies history | Q4 2025 | 25.07K | $626.67K | 0.00% | Reduce |
| MFS Investment Management history | Q2 2026 | 45.21K | $565.59K | 0.00% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 37.54K | $469.62K | 0.00% | Add |
| Polen Capital Management history | Q4 2025 | 15.21K | $380.15K | 0.00% | New |
| Citadel Advisors history | Q2 2026 | 28.50K | $356.54K | 0.00% | Reduce |
| CPP Investments history | Q2 2026 | 11.50K | $143.87K | 0.00% | New |
| Point72 Asset Management history | Q2 2026 | 2.20K | $27.52K | 0.00% | Reduce |
| Amundi US history | Q4 2024 | 1.84K | $10.57K | 0.00% | Hold |
| T. Rowe Price Associates history | Q2 2026 | 826.57K | $10.34K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 580 | $7.26K | 0.00% | Add |